[1] |
MANNS MP, LOHSE AW, VERGANI D. Autoimmune hepatitis-Update 2015[J]. J Hepatol, 2015, 62(1 Suppl): S100-S111. DOI: 10.1016/j.jhep.2015.03.005.
|
[2] |
ZHANG HP, YAN HP. Research advances in autoantibodies in autoimmune hepatitis[J]. J Clin Hepatol, 2020, 36(4): 749-753. DOI: 10.3969/j.issn.1001-5256.2020.04.007.
张海萍, 闫惠平. 自身免疫性肝炎自身抗体的研究进展[J]. 临床肝胆病杂志, 2020, 36(4): 749-753. DOI: 10.3969/j.issn.1001-5256.2020.04.007.
|
[3] |
ANAND L, CHOUDHURY A, BIHARI C, et al. Flare of autoimmune hepatitis causing acute on chronic liver failure: Diagnosis and response to corticosteroid therapy[J]. Hepatology, 2019, 70(2): 587-596. DOI: 10.1002/hep.30205.
|
[4] |
ALVAREZ F, BERG PA, BIANCHI FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999, 31(5): 929-938. DOI: 10.1016/s0168-8278(99)80297-9.
|
[5] |
HENNES EM, ZENIYA M, CZAJA AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology, 2008, 48(1): 169-176. DOI: 10.1002/hep.22322.
|
[6] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[7] |
MONTANO-LOZA AJ, SHUMS Z, NORMAN GL, et al. Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis[J]. Liver Int, 2012, 32(1): 85-92. DOI: 10.1111/j.1478-3231.2011.02502.x.
|
[8] |
Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol, 2016, 32(1): 9-22. DOI: 10.3969/j.issn.1001-5256.2016.01.002.
|
[9] |
WANG QX, MA X. Current status and perspectives of autoimmune hepatitis[J]. J Clin Hepatol, 2020, 36(4): 721-723. DOI: 10.3969/j.issn.1001-5256.2020.04.001.
王绮夏, 马雄. 自身免疫性肝炎的研究现状与展望[J]. 临床肝胆病杂志, 2020, 36(4): 721-723. DOI: 10.3969/j.issn.1001-5256.2020.04.001.
|
[10] |
MIELI-VERGANI G, VERGANI D, CZAJA AJ, et al. Autoimmune hepatitis[J]. Nat Rev Dis Primers, 2018, 4: 18017. DOI: 10.1038/nrdp.2018.17.
|
[11] |
ABE M, HIASA Y, MASUMOTO T, et al. Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis[J]. Hepatol Res, 2001, 21(3): 213-219. DOI: 10.1016/s1386-6346(01)00109-7.
|
[12] |
MONTANO-LOZA AJ, CARPENTER HA, CZAJA AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease[J]. Hepatology, 2007, 46(4): 1138-1145. DOI: 10.1002/hep.21787.
|
[13] |
van DEN BRAND FF, van DER VEEN KS, de BOER YS, et al. Increased mortality among patients with vs without cirrhosis and autoimmune hepatitis[J]. Clin Gastroenterol Hepatol, 2019, 17(5): 940-947. e2. DOI: 10.1016/j.cgh.2018.09.046.
|